Skip to main content
. 2009 Dec 28;16(3-4):122–128. doi: 10.2119/molmed.2009.00096

Figure 3.

Figure 3

Median levels of salivary MMPs in healthy controls (Control salivary samples; n = 16), patients treated with anti-TNF (Anti-TNF treated patient salivary samples; n = 14) and untreated patients (Untreated patient salivary samples; n = 21). The data is presented as percentage out of MMP9 levels in the control group. The significance values (**P < 0.01) were calculated for each group in comparison to its respective control.